Thames Capital Management LLC Purchases Shares of 331,276 Celanese Corporation $CE

Thames Capital Management LLC purchased a new stake in Celanese Corporation (NYSE:CEFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 331,276 shares of the basic materials company’s stock, valued at approximately $14,006,000. Celanese accounts for approximately 2.0% of Thames Capital Management LLC’s holdings, making the stock its 24th largest holding. Thames Capital Management LLC owned approximately 0.30% of Celanese as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. boosted its position in Celanese by 111.1% in the 2nd quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock valued at $28,000 after buying an additional 270 shares during the period. National Bank of Canada FI purchased a new position in Celanese in the 3rd quarter valued at approximately $34,000. Hartford Financial Management Inc. boosted its position in Celanese by 350.5% in the 4th quarter. Hartford Financial Management Inc. now owns 901 shares of the basic materials company’s stock valued at $38,000 after buying an additional 701 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Celanese by 100.0% during the 2nd quarter. Smartleaf Asset Management LLC now owns 662 shares of the basic materials company’s stock worth $38,000 after purchasing an additional 331 shares during the last quarter. Finally, Danske Bank A S purchased a new stake in shares of Celanese during the 3rd quarter worth $50,000. Hedge funds and other institutional investors own 98.87% of the company’s stock.

Celanese Price Performance

Shares of NYSE:CE opened at $53.10 on Friday. The company’s fifty day moving average price is $60.99 and its 200 day moving average price is $51.62. Celanese Corporation has a 12 month low of $35.13 and a 12 month high of $70.70. The company has a debt-to-equity ratio of 2.41, a current ratio of 1.38 and a quick ratio of 0.85. The firm has a market capitalization of $5.82 billion, a P/E ratio of -5.31, a P/E/G ratio of 0.32 and a beta of 0.81.

Celanese (NYSE:CEGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.85 EPS for the quarter, missing the consensus estimate of $0.88 by ($0.03). Celanese had a positive return on equity of 9.92% and a negative net margin of 11.54%.The company had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. During the same quarter in the prior year, the business earned $0.57 earnings per share. Celanese’s revenue was down 2.2% compared to the same quarter last year. Celanese has set its Q2 2026 guidance at 2.000-2.400 EPS. As a group, sell-side analysts predict that Celanese Corporation will post 5.8 earnings per share for the current fiscal year.

Celanese Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, May 11th. Investors of record on Monday, April 27th were paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.2%. The ex-dividend date was Monday, April 27th. Celanese’s dividend payout ratio (DPR) is currently -1.20%.

Analysts Set New Price Targets

CE has been the subject of several recent analyst reports. Zacks Research raised shares of Celanese from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. Wells Fargo & Company lifted their price objective on shares of Celanese from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Vertical Research raised shares of Celanese from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research report on Monday, March 9th. UBS Group lifted their price objective on shares of Celanese from $58.00 to $64.00 and gave the stock a “neutral” rating in a research report on Thursday, April 9th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Celanese in a research report on Tuesday. Ten equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $67.81.

View Our Latest Research Report on Celanese

About Celanese

(Free Report)

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.

Read More

Institutional Ownership by Quarter for Celanese (NYSE:CE)

Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.